GERALDINE SWEIKATA: Open Payments
NPI 1245709872 · GREENVALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 25 payments from 11 companies in 2025. Trend: 2023 $683 · 2024 $516 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $260 |
| Vifor Pharma, Inc. | 1 | $122 |
| Alnylam Pharmaceuticals Inc. | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| PFIZER INC. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| SCPHARMACEUTICALS INC. | 2 | $39 |
| Mannkind Corporation | 1 | $26 |
| Novo Nordisk Inc | 1 | $25 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
Products named: CARDIOMEMS, Veltassa, AMVUTTRA, FARXIGA, VYNDAQEL, Kerendia, FUROSCIX, AFREZZA.
Industry payments across NY — which companies pay providers there.
